Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Chetan S Karyekar, Shoba Ravichandran, Elsie Allen, Douglas Fleming, Robert Frederich Bristol-Myers Squibb, Princeton, NJ, USA Purpose: To assess safety and efficacy of saxagliptin in older patients with type 2 diabetes mellitus (T2DM). Patients and methods: This was a post hoc analysis of pooled d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karyekar CS, Ravichandran S, Allen E, Fleming D, Frederich R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
clinical trial
dipeptidyl peptidase-4
DPP-4 inhibitor
hypoglycemia
metformin
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/822cdf926c2d44ec9dc47f36d13382fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/822cdf926c2d44ec9dc47f36d13382fd

Ejemplares similares